secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001493152-22-033540
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte director Melinda Griffith to resign from board effective Jan 1, 2023
-----------------------------------------------------------------------------

- Resignation not due to any disagreement with company's operations, policies or practices.
- Griffith chairs Nominating/Corporate Governance Committee and serves on Sciences and Technology Committee.
- Effective date January 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315222033540/0001493152-22-033540-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315222033540/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-033540

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer